Evidence map›Paper›PMID 37033219›Full record

ArticleFrontiers in endocrinology2023

Melanocortin 4 receptor signaling in Sim1 neurons permits sexual receptivity in female mice.

Erin A Semple, Mitchell T Harberson, Baijie Xu, Rebecca Rashleigh, Tori L Cartwright, Jessica J Braun, Amy C Custer, Chen Liu, Jennifer W Hill

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Erin A SempleDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH, United States.
Mitchell T HarbersonDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH, United States.
Baijie XuCenter for Hypothalamic Research, University of Texas Southwestern, Dallas, TX, United States.
Rebecca RashleighDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH, United States.
Tori L CartwrightDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH, United States.
Jessica J BraunDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH, United States.
Amy C CusterDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH, United States.
Chen LiuCenter for Hypothalamic Research, University of Texas Southwestern, Dallas, TX, United States.
Jennifer W HillDepartment of Physiology and Pharmacology, University of Toledo College of Medicine, Toledo, OH, United States.
University of Toledo · USThe University of Texas Southwestern Medical Center · US

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
UT Southwestern NORCP30DK127984 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jeff G McDonald · 2022 to 2026
$7.4M
Hypothalamic Serotonin Receptors and Olanzapine-induced Metabolic SyndromeR01DK114036 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Chen Liu · 2017 to 2026
$4.2M
Astrocyte insulin resistance-induced neuroendocrine defects in pubertal delay and hypogonadotropic hypogonadismR01HD104418 · NICHD · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI Jennifer Wootton Hill · 2022 to 2026
$2.7M
Transcriptional Control of Melanocortin 4 Receptors and Obesity RiskR01DK130892 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Chen Liu · 2022 to 2026
$2.4M
Defective melanocortin signaling underlying T2D-associated erectile dysfunctionR01HD081792 · NICHD · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI HILL, JENNIFER WOOTTON · 2015 to 2019
$1.6M
NICHD NIH HHS R01 HD081792NIDDK NIH HHS P30 DK127984
6 · The paper itself

Abstract

Introduction: Female sexual dysfunction affects approximately 40% of women in the United States, yet few therapeutic options exist for these patients. The melanocortin system is a new treatment target for hypoactive sexual desire disorder (HSDD), but the neuronal pathways involved are unclear. Methods: In this study, the sexual behavior of female MC4R knockout mice lacking melanocortin 4 receptors (MC4Rs) was examined. The mice were then bred to express MC4Rs exclusively on Sim1 neurons (tbMC4RSim1 mice) or on oxytocin neurons (tbMC4ROxt mice) to examine the effect on sexual responsiveness. Results: MC4R knockout mice were found to approach males less and have reduced receptivity to copulation, as indicated by a low lordosis quotient. These changes were independent of body weight. Lordosis behavior was normalized in tbMC4R Discussion: These results implicate MC4R signaling in Oxt neurons in appetitive behaviors and MC4R signaling in Sim1 neurons in female sexual receptivity, while suggesting melanocortin-driven sexual function does not rely on metabolic neural circuits.

Indexed as

LordosisReceptor, Melanocortin, Type 4AnimalsBasic Helix-Loop-Helix ProteinsFemaleMaleMelanocortinsMiceMice, KnockoutNeuronsParaventricular Hypothalamic NucleusRepressor ProteinsBasic Helix-Loop-Helix ProteinsMelanocortinsReceptor, Melanocortin, Type 4Repressor ProteinsSim1 protein, mouselordosisMC4Rmelanocortinobesityoxytocinsexual behaviorsim1solicitation

Identifiers

PMID37033219
PMCPMC10080118
OpenAlexW4360866751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.